NADIA ELHOFY: Open Payments
NPI 1538553128 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 9 payments from 5 companies in 2025. Trend: 2023 $372 · 2024 $218 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 4 | $56 |
| Incyte Corporation | 2 | $47 |
| UCB, Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: VTAMA, OPZELURA, Bimzelx, Zoryve, DYSPORT.
Industry payments across CA — which companies pay providers there.
